scheduling
Pain: the new paradigm
Has pharmacy moved on from the codeine upscheduling? Our panel talks about the new paradigm in pain management by pharmacists In the second of our podcasts on pain treatment and …
Scheduling changes on the agenda
New proposals may see pharmacists dispensing downscheduled allergic rhinitis, migraine treatments, while caffeine powders are to be effectively banned The TGA’s medicine scheduling committee is set to rule on proposals …
The question of pain
In the first of a two-part series, Carlene McMaugh talks to a range of pharmacy experts about pain management. In particular we look at the impact of scheduling changes – …
Pharmacy-only NSAIDs: is it time?
Stakeholders have suggested that NSAIDs could be moved to pharmacy-only in a bid to avoid interactions such as the “triple whammy” with diuretics and ACE inhibitors Macquarie University researcher Dr …
The top ten
What were the ten most clicked stories on the AJP website over the last month? Regulatory and legal issues, Chemist Warehouse, scheduling changes and flu vaccines head up the list …
Staying the same
Mometasone to remain a mostly prescription product after downscheduling application is knocked back TGA regulators have rejected a proposal to move the corticosteroid mometasone to become a Schedule 3 product. …
Keeping it in pharmacy
Scheduling committee to decide on making some paracetamol products Pharmacist Only The TGA has requested that its scheduling committee examine whether a certain category of paracetamol medicine be upscheduled to …
Voltaren 2% gel to become general sale item
The medicines scheduling committee has ruled against the PSA and Guild, deciding that diclofenac up to 2% will be removed from the Schedule 2 entry from 1 October Late last …
Schedule change proposed for ED drug
New proposal put forward for Pharmacist-Only sildenafil category The TGA’s Advisory Committee on Medicines Scheduling is set to again review the possibility of creating an S3 category for sildenafil (Viagra). There …
Keeping to the script
Don’t fall back on opioids or codeine combination products after Feb 1 rescheduling deadline, prescribers warned, as AMA boss says stockpiling is not a concern Australian prescribers have been warned …
Missing an opportunity
Australian pharmacists may be missing a major opportunity to expand their professional role by being unaware of continued dispensing provisions A survey of Australian pharmacists’ attitudes to medicine reclassification (ie. …
Codeine decision expected within weeks
Will the success of MedsASSIST be enough to prevent the upscheduling of OTC codeine products? At the ASMI conference in October, Health Minister Sussan Ley suggested a final decision on the scheduling …